View Archive »
About The Cover
Hypoxia-dependent lipophilic molecular features phenotype of HCT116 colorectal cancer cells. See Valli et al.
|
|
Table of Contents
Editorial
Reviews
|
| Prostate cancer stem cells: deciphering the origins and pathways involved in prostate tumorigenesis and aggression |
|
https://doi.org/10.18632/oncotarget.2953
|
| 1900-1919 |
Priority Research Papers
|
| Hypoxia induces a lipogenic cancer cell phenotype via HIF1αdependent and independent pathways |
|
https://doi.org/10.18632/oncotarget.3058
|
| 1920-1941 |
Research Papers: Gerotarget (Focus on Aging)
|
| Methylβcyclodextrin upregulates collagen I expression in chronologicallyaged skin via its anticaveolin1 activity |
|
https://doi.org/10.18632/oncotarget.3039
|
| 1942-1953 |
Research Papers
|
| Novel receptor tyrosine kinase targeted combination therapies for imatinibresistant gastrointestinal stromal tumors GIST |
|
https://doi.org/10.18632/oncotarget.3021
|
| 1954-1966 |
|
| Hypoxia/HIF1α induces lapatinib resistance in ERBB2positive breast cancer cells via regulation of DUSP2 |
|
https://doi.org/10.18632/oncotarget.2806
|
| 1967-1980 |
|
| Group I Paks as therapeutic targets in NF2deficient meningioma |
|
https://doi.org/10.18632/oncotarget.2810
|
| 1981-1994 |
|
| Neoalbaconol induces cell death through necroptosis by regulating RIPKdependent autocrine TNFα and ROS production |
|
https://doi.org/10.18632/oncotarget.3038
|
| 1995-2008 |
|
| Multiple receptor tyrosine kinase activation attenuates therapeutic efficacy of the fibroblast growth factor receptor 2 inhibitor AZD4547 in FGFR2 amplified gastric cancer |
|
https://doi.org/10.18632/oncotarget.2987
|
| 2009-2022 |
|
| Sgo1 is a potential therapeutic target for hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.2764
|
| 2023-2033 |
|
| Functional repair of p53 mutation in colorectal cancer cells using transsplicing |
|
https://doi.org/10.18632/oncotarget.2988
|
| 2034-2045 |
|
| Claudin7 promotes the epithelial – mesenchymal transition in human colorectal cancer |
|
https://doi.org/10.18632/oncotarget.2858
|
| 2046-2063 |
|
| Amyloid precursorlike protein 2 APLP2 affects the actin cytoskeleton and increases pancreatic cancer growth and metastasis |
|
https://doi.org/10.18632/oncotarget.2990
|
| 2064-2075 |
|
| Mesenchymal stem cells are resistant to carbon ion radiotherapy |
|
https://doi.org/10.18632/oncotarget.2857
|
| 2076-2087 |
|
| mTOR kinase inhibitors synergize with histone deacetylase inhibitors to kill Bcell acute lymphoblastic leukemia cells |
|
https://doi.org/10.18632/oncotarget.2992
|
| 2088-2100 |
|
| Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and Xrays through senescence and mitotic catastrophe |
|
https://doi.org/10.18632/oncotarget.2937
|
| 2101-2119 |
|
| TGFβ1 induces epigenetic silence of TIP30 to promote tumor metastasis in esophageal carcinoma |
|
https://doi.org/10.18632/oncotarget.2940
|
| 2120-2133 |
|
| DNA damage induces GDNF secretion in the tumor microenvironment with paracrine effects promoting prostate cancer treatment resistance |
|
https://doi.org/10.18632/oncotarget.3040
|
| 2134-2147 |
|
| Targeting a ribonucleoprotein complex containing the caprin1 protein and the cMyc mRNA suppresses tumor growth in mice: an identification of a novel oncotarget |
|
https://doi.org/10.18632/oncotarget.3236
|
| 2148-2163 |
|
| Afatinib induces apoptosis in NSCLC without EGFR mutation through Elk1mediated suppression of CIP2A |
|
https://doi.org/10.18632/oncotarget.2941
|
| 2164-2179 |
|
| γH2AX promotes hepatocellular carcinoma angiogenesis via EGFR/HIF1α/VEGF pathways under hypoxic condition |
|
https://doi.org/10.18632/oncotarget.2942
|
| 2180-2192 |
|
| DCLK1 is a broadly dysregulated target against epithelialmesenchymal transition focal adhesion and stemness in clear cell renal carcinoma |
|
https://doi.org/10.18632/oncotarget.3059
|
| 2193-2205 |
|
| Hypoxia upregulates SERPINB3 through HIF2α in human liver cancer cells |
|
https://doi.org/10.18632/oncotarget.2943
|
| 2206-2221 |
|
| SKP2 cooperates with NRas or AKT to induce liver tumor development in mice |
|
https://doi.org/10.18632/oncotarget.2945
|
| 2222-2234 |
|
| βIIITubulin: A novel mediator of chemoresistance and metastases in pancreatic cancer |
|
https://doi.org/10.18632/oncotarget.2946
|
| 2235-2249 |
|
| Inhibition of HIF1α by PX478 enhances the antitumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.2948
|
| 2250-2262 |
|
| RUNX1 an androgen and EZH2regulated gene has differential roles in ARdependent and independent prostate cancer |
|
https://doi.org/10.18632/oncotarget.2949
|
| 2263-2276 |
|
| MicroRNA26a promotes anoikis in human hepatocellular carcinoma cells by targeting alpha5 integrin |
|
https://doi.org/10.18632/oncotarget.2956
|
| 2277-2289 |
|
| The antimicrobial peptide pardaxin exerts potent antitumor activity against canine perianal gland adenoma |
|
https://doi.org/10.18632/oncotarget.2959
|
| 2290-2301 |
|
| Targeting the microRNA21/AP1 axis by 5fluorouracil and pirarubicin in human hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.2955
|
| 2302-2314 |
|
| By promoting cell differentiation miR100 sensitizes basallike breast cancer stem cells to hormonal therapy |
|
https://doi.org/10.18632/oncotarget.2962
|
| 2315-2330 |
|
| Immunohistochemical quantification of the cobalamin transport protein cell surface receptor and Ki67 in naturally occurring canine and feline malignant tumors and in adjacent normal tissues |
|
https://doi.org/10.18632/oncotarget.3206
|
| 2331-2348 |
|
| FOXM1 confers to epithelialmesenchymal transition stemness and chemoresistance in epithelial ovarian carcinoma cells |
|
https://doi.org/10.18632/oncotarget.2957
|
| 2349-2365 |
|
| The tetraspanins CD151 and Tspan8 are essential exosome components for the crosstalk between cancer initiating cells and their surrounding |
|
https://doi.org/10.18632/oncotarget.2958
|
| 2366-2384 |
|
| The antileukemic activity of sodium dichloroacetate in p53mutated/null cells is mediated by a p53independent ILF3/p21 pathway |
|
https://doi.org/10.18632/oncotarget.2960
|
| 2385-2396 |
|
| The BRCA1/2directed miRNA signature predicts a good prognosis in ovarian cancer patients with wildtype BRCA1/2 |
|
https://doi.org/10.18632/oncotarget.2963
|
| 2397-2406 |
|
| Resistance to everolimus driven by epigenetic regulation of MYC in ER+ breast cancers |
|
https://doi.org/10.18632/oncotarget.2964
|
| 2407-2420 |
|
| MicroRNA135b a HSF1 target promotes tumor invasion and metastasis by regulating RECK and EVI5 in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.2965
|
| 2421-2433 |
|
| Chloride channel3 promotes tumor metastasis by regulating membrane ruffling and is associated with poor survival |
|
https://doi.org/10.18632/oncotarget.2966
|
| 2434-2450 |
|
| Metabolic reprogramming of metastatic breast cancer and melanoma by let7a microRNA |
|
https://doi.org/10.18632/oncotarget.3235
|
| 2451-2465 |
|
| Genetic alterations of histone lysine methyltransferases and their significance in breast cancer |
|
https://doi.org/10.18632/oncotarget.2967
|
| 2466-2482 |
|
| MicroRNA500 sustains nuclear factorκB activation and induces gastric cancer cell proliferation and resistance to apoptosis |
|
https://doi.org/10.18632/oncotarget.2800
|
| 2483-2495 |
|
| Clinically relevant genes and regulatory pathways associated with NRASQ61 mutations in melanoma through an integrative genomics approach |
|
https://doi.org/10.18632/oncotarget.2954
|
| 2496-2508 |
|
| Stabilization of LKB1 and Akt by neddylation regulates energy metabolism in liver cancer |
|
https://doi.org/10.18632/oncotarget.3191
|
| 2509-2523 |
|
| Mutation of Vav1 adaptor region reveals a new oncogenic activation |
|
https://doi.org/10.18632/oncotarget.2629
|
| 2524-2538 |
Clinical Research Papers
|
| Coexpression of PKM2 and TRIM35 predicts survival and recurrence in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.2991
|
| 2539-2548 |
|
| Mutation profiling of tumor DNA from plasma and tumor tissue of colorectal cancer patients with a novel highsensitivity multiplexed mutation detection platform |
|
https://doi.org/10.18632/oncotarget.3041
|
| 2549-2561 |
|
| Fibroblast growth factor receptor 1 gene amplification is associated with poor survival in patients with resected esophageal squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.2944
|
| 2562-2572 |
|
| Genetic polymorphisms in the vitamin D pathway in relation to lung cancer risk and survival |
|
https://doi.org/10.18632/oncotarget.2951
|
| 2573-2582 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
